NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Menopause



Two new studies address hormone therapy post-WHI



December 26th, 2002

Hormone therapy (HT) is the subject of two studies in the December 2002 issue of Obstetrics & Gynecology: the Women's Contraceptive and Reproductive Experiences Study of the National Institute of Child Health and Human Development (NICHD), and a data analysis from the Heart and Estrogen/Progestin Replacement Study (HERS).

Results from this NICHD-funded study of 3823 postmenopausal women were consistent with the recent Women's Health Initiative study results on continuous combined HT (defined here as estrogen combined with 25-31 days per month of progestin use). Continuous combined HT was associated with an increased breast cancer risk among current users of the...


Source: Women's Health Weekly (2002-12-26)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login